Filter Results:
(6,556)
Show Results For
- All HBS Web
(6,556)
- People (18)
- News (2,168)
- Research (3,607)
- Events (3)
- Multimedia (220)
- Faculty Publications (2,784)
Show Results For
- All HBS Web
(6,556)
- People (18)
- News (2,168)
- Research (3,607)
- Events (3)
- Multimedia (220)
- Faculty Publications (2,784)
- 01 Jun 2020
- Working Paper Summaries
Spreading the Health: Americans' Estimated and Ideal Distributions of Death and Health(care)
- July 2016
- Article
Economic Implications of the Society for Assisted Reproductive Technology Embryo Transfer Guidelines: Healthcare Dollars Saved by Reducing Iatrogenic Triplets
By: Malinda S. Lee, Brady T. Evans, Ariel Dora Stern and Mark D. Hornstein
Objective: To estimate the national cost savings resulting from reductions in higher-order multiple (HOM) live births (defined as three or more fetuses), following the initial publication of the Society for Assisted Reproductive Technology (SART) guidelines on ET in... View Details
Lee, Malinda S., Brady T. Evans, Ariel Dora Stern, and Mark D. Hornstein. "Economic Implications of the Society for Assisted Reproductive Technology Embryo Transfer Guidelines: Healthcare Dollars Saved by Reducing Iatrogenic Triplets." Fertility and Sterility 106, no. 1 (July 2016): 189–195.e3.
- July 1972 (Revised November 1980)
- Case
Richardson Center for the Blind
Shapiro, Benson P. "Richardson Center for the Blind." Harvard Business School Case 573-004, July 1972. (Revised November 1980.)
- September 2013 (Revised June 2015)
- Case
Fortis Healthcare: Transnational Hospital Network
By: Regina E. Herzlinger, Pushwaz Virk and Natalie Kindred
Fortis, India's largest for-profit hospital chain, must decide if its expensive expansion into the South East Asia market makes sense. View Details
- 01 Mar 2013
- News
Health-Care Forum's Rx for US System
Shape up, people! That was the message for both the health-care industry and the public at a November forum of more than 150 medical practitioners, health-industry executives, academics, and others who gathered at HBS. Titled "Healing... View Details
Keywords: Health, Social Assistance
- 17 Aug 2011
- News
Breath of Life
Green: Participating in the stem-cell revolution. Courtesy David Green It was the kind of medical miracle that experts say will one day be commonplace. In June, an artificial trachea (windpipe), infused with a tracheal cancer patient’s own stem cells, was successfully... View Details
- November 2014
- Teaching Note
Claritas Genomics
By: Robert F. Higgins and Matthew G. Preble
Dr. Patrice Milos is the first CEO of Claritas Genomics (Claritas) and she faces a number of challenges in scaling the young company. Claritas was formed around a lab spun out from Boston Children's Hospital (BCH) which had performed genomic tests for the hospital. Now... View Details
- 16 Sep 2014
- Research & Ideas
Has Apple Reinvented the Watch?
especially from a consumer health and wellness standpoint. It's where we know the health care industry is moving. Q: Apple has always been known... View Details
- September 2022
- Article
How Emerging Telehealth Models Challenge Policymaking
By: Mitchell Tang, Michael E Chernew and Ateev Mehrotra
Policy Points
Current telehealth policy discussions are focused on synchronous video and audio telehealth visits delivered by traditional providers and have neglected the growing number of alternative telehealth offerings.
These alternative... View Details
Tang, Mitchell, Michael E Chernew, and Ateev Mehrotra. "How Emerging Telehealth Models Challenge Policymaking." Milbank Quarterly 100, no. 3 (September 2022): 650–672.
- September 2016 (Revised October 2018)
- Case
Springfield Hospital
By: Susanna Gallani and Robert Kaplan
One of the key roles of costing systems is to support the evaluation of performance and facilitate appropriate resource allocations. Through participation in a comparative cost study, management at Springfield Hospital, known for its heavy focus on operational... View Details
Keywords: Time-Driven Activity-Based Costing; Variance Analysis; Activity Based Costing and Management; Health Care and Treatment; Health Industry
Gallani, Susanna, and Robert Kaplan. "Springfield Hospital." Harvard Business School Case 117-025, September 2016. (Revised October 2018.)
- 1977
- Chapter
Cost Benefit Analysis of Surgery: Some Additional Caveats and Interpretation
By: Jerry R. Green
Green, Jerry R. "Cost Benefit Analysis of Surgery: Some Additional Caveats and Interpretation." In Costs, Risks and Benefits of Surgery, edited by J. Bunker, B. Barnes, and F. Mosteller. New York: Oxford University Press, 1977.
- January 2020
- Teaching Note
GeBBS Healthcare Solutions: Did You Ever Have to Make Up Your Mind? (A) and (B)
This teaching note is meant to accompany “GeBBS Healthcare Solutions: Did You Ever Have to Make Up Your Mind? (A),” HBS No. 820-041, and “GeBBS Healthcare Solutions: Did You Ever Have to Make Up Your Mind? (B),” HBS No. 820-074. The cases follow Nitin Thakor, President... View Details
- January 2005 (Revised March 2006)
- Case
Molecular Insight Pharmaceuticals, Inc.
By: Richard G. Hamermesh and Edwin W. Parkinson III
Molecular Insight has developed a novel biopharmaceutical to detect heart attacks. The company's unique approach to intellectual property protection uses the Hatch Waxman Act and the Orphan Drug Act. The company is struggling to raise $7 million in Series B financing.... View Details
Keywords: Intellectual Property; Health Care and Treatment; Pharmaceutical Industry; Pharmaceutical Industry
Hamermesh, Richard G., and Edwin W. Parkinson III. "Molecular Insight Pharmaceuticals, Inc." Harvard Business School Case 805-067, January 2005. (Revised March 2006.)
- 01 Jun 2013
- News
Lab Work
After 16 years at the Australian technology-transfer organization UniQuest, managing director David Henderson (MBA 1989) is moving on to new challenges. Looking back on the experience of shepherding technologies from the university to the marketplace—the... View Details
- 01 Dec 2019
- News
The Race Against Resistance
resistance, we will fall back to a time when simple infections killed people.” “We are approaching a cliff. If we don’t take steps to slow down or stop drug resistance, we will fall back to a time when simple infections killed people.” The World View Details
Keywords: Lisa Scanlon Mogolov
- 10 Apr 2013
- Research & Ideas
Learning Curve: Making the Most of Outsourcing
telemedicine and specialized providers of niche services such as retail clinics, single-specialty hospitals, and disease management companies. The research, he says, reflects the traditional pendulum swing in health View Details
- 01 Dec 2011
- News
Faculty Research Online
employees they hire and the way they socialize those employees. See http://hbswk.hbs.edu/item/6795.html. Making the Case for Consumer-Driven Health Care Even as “Obamacare” becomes an issue in the 2012... View Details
- May 2012 (Revised February 2014)
- Teaching Note
Learning About Reducing Hospital Mortality at Kaiser Permanente
By: Anita Carson Tucker